Tristel PLC Update to Executive Performance Share Plan 2021 (2801H)

TIDMTSTL

RNS Number : 2801H

Tristel PLC

02 December 2020

Tristel plc

("Tristel" or the "Company")

Update to Executive Performance Share Plan 2021

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the terms of the options to be granted under the rules of the Tristel plc Executive Performance Share Plan 2021 (the "Plan") to be put to shareholders for approval at the Annual General Meeting of the Company to be held on 10.00 a.m. on 15 December 2020 (the "AGM") will be amended to include more onerous performance targets for the vesting of the options.

A revised copy of Appendix I of the Notice of AGM summarising the principal terms of the Plan and of the options to be granted under the Plan and copies of the proposed option agreements incorporating, in each case, the more onerous performance targets, together with the full text of the Plan, the Notice of AGM and the Form of Proxy, are available for inspection on the Company's website at https://www.tristel.com/uk/investor-centre/agm-notices-proxies .

Any shareholder who wishes to change any proxy instructions already submitted, may do so by submitting a new proxy appointment using the methods set out in the notes to the Notice of AGM.

Shareholders are reminded that proxies must be received no later than 10.00 a.m. on 11 December 2020.

For further information please contact:

 
 Tristel plc                                                 Tel: [phone] 
 Paul Swinney, Chief Executive 
  Officer 
 Liz Dixon, Finance Director 
 
 Walbrook PR Ltd                   Tel: [phone] or [e-mail] 
 Paul McManus                                                Mob: [phone] 
 Lianne Cawthorne                                            Mob: [phone] 
 
 finnCap                                                     Tel: [phone] 
 Geoff Nash/ Giles Rolls (Corporate 
  Finance) 
 Alice Lane (ECM) 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUPGUAPUPUGUP

(END) Dow Jones Newswires

December 02, 2020 09:00 ET (14:00 GMT)